Br. J. Pharmac., 60, 35-43 (1977). |
Patent Abst. of Japan, vol. 9, No. 301 (C-316) [2024], Nov. 28, 1985; & JP-A-60 139,671 (Banyu Seiyaku K.K.) 24 Jul. 1985. |
Drugs of the Future, vol. 14, No. 4, 1989, pp. 331-333; "NB-818". |
Japan J. Pharmacol., vol. 40, 1986, pp. 399-409; J. Nagaura et al.: "Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity". |
Clinical Pharmacy, vol. 6, Apr. 1987, pp. 292-306, American Society of Hospital Pharmacists, Inc. C. M. Quandt, et al.: "Current concepts in clinical therapeutics: Ischemic cerebrovascular disease" *Page 303, right-hand column, lines 12-34*. |
Acta Pharmacol. Et Toxicol., vol. 57, suppl. II, 1985, pp. 31-43; K.-E. Anderson: "Some extra-cardiac effects of diltiazem and other calcium entry blockers" *P. 33, section Cerebral arterial system* (1985). |
"Archives internat . . . Therapie," vol. 297--Nos. 1/2 Jan./Feb. 1989. |
"Archives internat . . . Therapie," vol. 291--Nos. 1/2 Jan./Feb. 1988. |
"Life Sciences," vol. 43, 1715-1723 (1988). |
"Journal of Pharm. & Exp. Thera.," vol. 246, No. 2 (1988) Nishikibe et al. |
Ohtomo, Japanese Pharmacology and Therapeutics, vol. 20, No. 9 (1992) pp. 125-148. |